Renaissance Technologies LLC Lowers Stake in Utah Medical Products, Inc. (NASDAQ:UTMD)

Renaissance Technologies LLC cut its position in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 2.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 227,114 shares of the medical instruments supplier’s stock after selling 5,400 shares during the quarter. Renaissance Technologies LLC owned approximately 0.06% of Utah Medical Products worth $15,173,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of UTMD. Quadrature Capital Ltd grew its holdings in shares of Utah Medical Products by 177.6% during the first quarter. Quadrature Capital Ltd now owns 32,310 shares of the medical instruments supplier’s stock worth $2,294,000 after buying an additional 20,671 shares in the last quarter. Los Angeles Capital Management LLC grew its holdings in shares of Utah Medical Products by 154.3% during the second quarter. Los Angeles Capital Management LLC now owns 33,283 shares of the medical instruments supplier’s stock worth $2,224,000 after buying an additional 20,197 shares in the last quarter. Penn Mutual Asset Management LLC grew its holdings in shares of Utah Medical Products by 46.3% during the fourth quarter. Penn Mutual Asset Management LLC now owns 53,093 shares of the medical instruments supplier’s stock worth $4,471,000 after buying an additional 16,810 shares in the last quarter. Isthmus Partners LLC grew its holdings in shares of Utah Medical Products by 56.8% during the first quarter. Isthmus Partners LLC now owns 35,602 shares of the medical instruments supplier’s stock worth $2,532,000 after buying an additional 12,903 shares in the last quarter. Finally, Vanguard Group Inc. grew its holdings in Utah Medical Products by 7.3% in the first quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock valued at $13,023,000 after purchasing an additional 12,402 shares during the period. 69.60% of the stock is currently owned by hedge funds and other institutional investors.

Utah Medical Products Stock Performance

Utah Medical Products stock opened at $66.31 on Friday. Utah Medical Products, Inc. has a 1 year low of $65.60 and a 1 year high of $89.15. The firm has a 50 day moving average price of $68.19 and a 200 day moving average price of $68.21. The company has a market cap of $230.76 million, a price-to-earnings ratio of 14.74 and a beta of 0.08.

Utah Medical Products (NASDAQ:UTMD) last released its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.98 earnings per share (EPS) for the quarter. Utah Medical Products had a net margin of 33.56% and a return on equity of 12.41%. The firm had revenue of $10.40 million during the quarter.

Utah Medical Products Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 4th. Shareholders of record on Friday, September 20th will be given a dividend of $0.30 per share. The ex-dividend date of this dividend is Friday, September 20th. This represents a $1.20 dividend on an annualized basis and a yield of 1.81%. Utah Medical Products’s dividend payout ratio (DPR) is 26.67%.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.